Abstract

Clinical application of perilla oil in breast cancer

Author(s): Kapil Kumar, Deepak Teotia & Ali Gamal Ahmed Al-kaf

Objective: To study the clinical effect of perilla oil on breast cancer.

Methods: A total of 86 breast cancer patients enrolled in our hospital from February 2015 to March 2016 were selected as the objects and divided into control group as well as observation group with the same quantity of cases in each group. The control group were given drug treatment of epirubicin combined with paclitaxel while the observation group were additionally treated with perilla oil capsules besides the treatment in the control group. The clinical efficacy was compared between the two groups.

Results: In terms of short-term efficacy, there was no statistically significant difference in total effective rate between the two groups (P>0.05); Compared with the control group, the patient’s quality of life in the observation group was significantly higher of statistically significant difference (P<0.05); The adverse reaction rate of the observation group was markedly lower than that of the control group with statistically significant difference in between (P<0.05).

Conclusion: In breast cancer patients, the treatment of perilla oil plus paclitaxel combined with epirubicin has more obvious effect and is worth popularizing in clinical practices.